跳转至内容
Merck
CN

122882

Sigma-Aldrich

2-氨基-4-氯-6-甲基嘧啶

97%

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C5H6ClN3
CAS号:
分子量:
143.57
Beilstein:
114297
EC 号:
MDL编号:
UNSPSC代码:
12352100
PubChem化学物质编号:
NACRES:
NA.22

质量水平

方案

97%

表单

solid

mp

183-186 °C (lit.)

溶解性

acetic acid: soluble 50 mg/mL, clear, colorless to faintly yellow

官能团

chloro

SMILES字符串

Cc1cc(Cl)nc(N)n1

InChI

1S/C5H6ClN3/c1-3-2-4(6)9-5(7)8-3/h2H,1H3,(H2,7,8,9)

InChI key

NPTGVVKPLWFPPX-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

2-Amino-4-chloro-6-methylpyrimidine is a nitification inhibitor.

应用

2-Amino-4-chloro-6-methylpyrimidine was used to study the influence of chlorine substitution in pyrimidine ring on proton donor ability of amino group in 2-aminopyrimidine.

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Effects of nitrification inhibitors on denitrification of nitrate in soil.
Bremner JM andYeomans JC.
Biology and Fertility of Soils, 2(4), 173-179 (1986)
Influence of chlorine-substitution in pyrimidine ring on proton donor ability in H-bond and parameters of amino group of 2-amino pyrimidine.
Borisenko VE, et al.
Vibrational Spectroscopy, 37(1), 97-109 (2005)
T Jayavarthanan et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 97, 811-824 (2012-08-21)
The solid phase FTIR and FT-Raman spectra of 2-amino-4-chloro-6-methylpyrimidine (2A4Cl6MP) have been recorded in the regions 400-4000 and 50-4,000 cm(-1), respectively. The spectra have been interpreted interms of fundamentals modes, combination and overtone bands. The structure of the molecule has
J A Hutter et al.
Biochemistry, 26(7), 1969-1973 (1987-04-07)
Thiaminase I from Bacillus thiaminolyticus strain Matsukawa et Misawa is completely and irreversibly inhibited by treatment with 4-amino-6-chloro-2-methylpyrimidine. Inhibition is a time-dependent first-order process, exhibiting a half-time of 4 h at an inhibitor concentration of 5 mM. A specific active-site-directed
Christer B Aakeröy et al.
Pharmaceutics, 3(3), 601-614 (2011-01-01)
In the pharmaceutical industry, co-crystals are becoming increasingly valuable as crystalline solids that can offer altered/improved physical properties of an active pharmaceutical ingredient (API) without changing its chemical identity or biological activity. In order to identify new solid forms of

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门